Human neutrophils in the presence of serum containing anti-amoeba antibody either lacked amoebicidal activity or were poorly amoebicidal for Acanthamoeba culbertsoni. In contrast, neutrophils preexposed for 1 h to supernatants from human peripheral blood mononuclear leukocytes (MNLs) stimulated with phytohemagglutinin demonstrated significant amoeba killing in the presence of serum containing anti-acanthamoeba antibodies. Supernatant from MNL cultured in the absence of phytohemagglutinin were not effective in stimulating significant activity in the neutrophils. Serum containing antibody promoted the adherence of many neutrophils to one amoeba. There was no significant difference between the ability of neutrophils treated with supernatants from stimulated MNLs (stimulated conditioned medium [sCM]) and supernatants from nonstimulated MNLs (nonstimulated conditioned medium [nsCM]) in their binding to acanthamoeba. The effects of sCM on neutrophils was a general phenomenon. For example, the sCM but not the nsCM enhanced the antibody-dependent neutrophil-mediated cytotoxicity against three tumor targets (K562 erythroid myeloid leukemia cell line, B16 melanoma, and P815 (DBA/2 mastocytoma). Furthermore, the sCM but not the nsCM increased the bactericidal (against Staphylococcus aureus and Streptococcus pneumoniae) and fungicidal (against Torulopsis glabrata) activity of the neutrophil. The sCM but not the nsCM contained activities which inhibited neutrophil migration and stimulated a respiratory burst in these leukocytes. These results suggest that the neutrophil antimicrobial power can be increased by exposing the leukocytes to MNL mediators.
The neutrophil has often been considered important in host resistance to bacterial and fungal infections, and recent evidence suggests its importance in resistance to helminthic, protozoal, and malignant diseases. However, it was only most recently that serious consideration was given to the possible modulation of neutrophil antimicrobial functions by mediators, released by lymphocytes and monocytemacrophages, which are distinct from antibodies and their fragments and which can be tentatively referred to as lymphokines and monokines (3, 11, 25, 27, 28, 33, 43) . Accordingly, these factors are likely to influence the outcome of diseases in which neutrophils play an important role, but unfortunately this area of neutrophil biology is ill defined and controversial.
In this laboratory we have been interested in defense systems against free-living amoebae which cause disease in humans. These are considered to belong to two genera, Naegleria and Acanthamoeba. Only one species in the former, Naegleriafowleri, has been shown to infect humans, producing a well-defined, acutely fatal meningoencephalitis (1, 4, 24, 40) resembling a fulminating bacterial meningitis. Species of Acanthamoeba cause either a chronic meningoencephalitis or chronic eye infections (29, 30) . To date there is no effective treatment for these diseases (15, 24; Y. H. Thong and A. Ferrante, Experimental Pharmacology, in E. G. Rondanelli (ed.), Amphizoic Amoebae: Human Pathology, in press). For this reason we have pursued studies on host interaction with these amoebae and have recently presented evidence that for human neutrophils to kill N. fowleri cells the leukocytes must be pretreated with conditioned medium (CM) from phytohemagglutinin (PHA)-608 FERRANTE AND ABELL presence of 5% CO-air and under conditions of high humidity.
Bacteria and fungi. The bacteria and fungi used in this study were those used previously in this laboratory. These were Staphylococcus aureus (41) , Streptococcus pneumoniae (32) , and Torulopsis glabrata (42) . Viable bacteria and fungi were determined by their ability to form colonies on blood agar and Sabouraud dextrose agar, respectively.
Preparation of leukocytes. Blood from healthy volunteers was drawn into tubes containing lithium heparin. MNLs and neutrophils were prepared by a rapid single-step technique (16, 19, 20) . The blood was layered onto a Ficoll-Hypaque solution of density 1.114 g/ml and centrifuged at 400 x g for 20 min. After centrifugation, the leukocytes resolved into two distinct bands. The MNLs settled and formed a band at the interface. The neutrophils collected in a second band approximately 1 cm below the first. During the centrifugation the erythrocytes sedimented to the bottom. The methodology allows the preparation of neutrophils in high yields and at a purity of greater than 96%. The viability of both leukocyte populations was greater than 99%, as judged by the ability of cells to exclude trypan blue under previously described conditions (14) .
Preparation of antiserum. Rabbits were immunized with sonicated A. culbertsoni cells under conditions previously described for mice (35) . Rabbits received three to four injections, each of 106 amoebae, given subcutaneously 2 weeks apart. In mice this antigen has been shown to induce a high level of resistance to acanthamoeba infection (35) . Antiserum against K562 and B16 melanoma was also raised in rabbits. Rabbits were given a primary injection (subcutaneously) of 5 x 106 tumor cells in incomplete Freund adjuvant. The animals were given three more injections of tumors, each 2 weeks apart and in the absence of adjuvant. Blood was taken from these rabbits 1 week after the final immunization, and antiserum was prepared. Amoeba agglutination assay. Twofold dilutions were made of the serum or serum fractions in medium 199 (volume, 0.1 ml) in wells (flat bottomed) of Linbro microtiter plates (Flow Laboratories, McLean, Va.). To each was added 0.1 ml of a solution containing 5 x 105 amoeba per ml. The plates were incubated at 37°C and observed microscopically for amoeba agglutination after 2 h of incubation. The titer was arbitrarily chosen as the reciprocal of the highest serum dilution at which agglutination could be observed.
Adsorption of serum. The adsorption procedure was carried out at 2 to 4°C. A total of 108 amoebae were pelleted by centrifugation, and the pellet was suspended in 1 ml of heat-inactivated antiserum and incubated for 1 h. After incubation, the amoebae were removed and the serum was subjected to two additional adsorption steps. The serum was finally filtered through a membrane filter (pore size, 0.22 ,um; Millipore Corp.). After adsorption the serum contained an agglutination titer of <2 (the original titer was 32).
Preparation of MNL-conditioned medium. The MNLs, at a concentration of 2 x 106 cells per ml, were incubated in RPMI 1640 medium containing 10% heat-inactivated FCS in either the presence or absence of PHA. The mitogen was used at optimal concentration of 1 sg/ml (19) . The cells were incubated at 370C for 24 h in an atmosphere of 5% C02-air and under conditions of high humidity. The MNLs were washed three times with medium, suspended in fresh medium containing 10% FCS, and reincubated for 48 h. The cell-free supernatants were prepared by centrifugation and filtration through a (0.22-pm-pore-size Millipore filter). The supernatants from PHA-stimulated MNLs will be referred to as stimulated conditioned medium (sCM), and those from MNL cultured in the absence of mitogen will be referred to as nonstimulated conditioned medium (nsCM).
Preparation of trinitrophenyl (TNP)-labeled P815 tumor cells. P815 cells were labeled with TNP essentially as described by Vadas et al. (44) . The P815 cells were reacted with 10 mM trinitrobenzenesulfonic acid in phosphatebuffered saline containing 1% FCS at room temperature for 20 min at pH 7.3. After incubation the cells were washed and were ready for isotope labeling.
Labeling of tumor cells with Na251CrO4. The cells were suspended in RPMI 1640 medium (with 10% FCS) to a concentration of 5 x 106/ml, and to these was added 100 pLCi of Na251CrO4 (Amersham, Australia Pty. Ltd.) After an incubation period of 1 h, the cells were washed and adjusted to 105/ml for use in cytotoxicity assays.
Treatment of neutrophils with CM. To 0.25 ml of a solution containing 4 x 107 neutrophils per ml was added 0.75 ml of sCM or nsCM, and these solutions were incubated at 37°C for 1 h. After incubation, the leukocytes were washed three times in medium 199 and used immediately in assays.
Amoebicidal assay. The amoebicidal assay was conducted in the same way as that with N. fow'leri (11) . In the assay, 2.5 x 106 neutrophils were added to 2.5 x 104 amoebae. The contents were made up in a total volume of 0.5 ml by using medium 199 Bactericidal and fungicidal assays. Bactericidal and fungicidal assays were performed essentially as described previously (32, 41, 42) . Neutrophils (106) were mixed with a concentration of S. oiireis in the presence of 5% human AB serum in a 0.5-ml final volume with Hanks balanced salt solution. The tubes were gassed with 5% CO,-air and incubated at 37°C with end-to-end mixing. At the times indicated in Results, 0.1-ml samples were taken and diluted in sterile distilled water, and serial dilutions were plated on blood agar to determine the number of viable bacteria. Assays for measuring neutrophil-mediated killing of Streptococcus pnfcflwiioiici cells were conducted as for S. aiii-eiis, with the exception that 10% human serum from a volunteer who had received a pneumococcal vaccine was used. The opportunistic human fungus T. glabriata was used in the fungicidal assay. This assay was conducted in a manner similar to the measurement of S. iiarels killing (5% human AB serum was used). The fungi were plated onto Sabouraud dextrose agar plates to determine viability.
Hexose monophosphate (HMP) shunt assay. The neutrophil-HMP shunt activity was measured as described previously (12) . A 20-ml and 5-ml volume glass scintillation vial was used to make a container with an inner and an outer vessel. The outer vessel received 2 x 106 neutrophils, 0.024 pCi of L-[1-'4C]glucose (3. 96 mCi/mmol), and 4% autologous serum. All solutions were made up in glucose-free Earle balanced salt solution, and the final volume in each outer vessel was 1.0 ml. To the inner vessel was added 0.1 ml of 5 N NaOH to absorb the 14CO2 evolved. The containers were placed in a shaking water bath at 37°C for various periods. After incubation the radioactivity in the NaOH was counted by liquid scintillation. Assays were conducted in triplicate.
Chemiluminescence. Neutrophils were suspended in Hanks balanced salt solution (with no phenol red). The leukocyte concentration was adjusted to 5 x 106/ml, dispensed in 0.1-ml aliquots (containing 5% human AB serum), and incubated at 37°C in the dark. After 15 min of incubation, 0.9 ml of 10-6 M luminol was added, the tubes were placed in a lightproof chamber of the luminometer (LKB Wallac), and the resulting light output in millivolts was recorded by digital printout set to 1-or 10-s recording intervals. Assays were conducted in duplicate.
Measurement of neutrophil migration. Neutrophil migration was measured as described by Nelson et al. (31) with some modification (9) . Wells (diameter, 2.5 mm) were cut with a template into 1% agarose gel in medium 199 (supplemented with 10% heat-inactivated FCS) contained in tissue culture petri dishes (60 by 15 mm). A 5-,ul portion of a neutrophil suspension (2 x 107/ml) was added to each well, and the dishes were incubated at 37°C for 90 min in an atmosphere of 5% CO,-air and under conditions of high humidity. After incubation the migration distance was measured under an inverted microscope (with phase) by using an eyepiece grid. Each testing involved setting up each sample in two separate dishes and in four wells per dish.
Statistical analysis. In all cases the data were analyzed by the unpaired t test. In the amoebicidal assays, all reactions were compared with the control (amoebae incubated in the presence of FCS only). In other assays the comparisons made are indicated in the figure legends.
RESULTS
Effect of sCM-treated neutrophils on amoebae. Neutrophils preincubated with sCM or nsCM were examined for amoebicidal activity against A. culbertsoni. The results showed that nsCM-treated neutrophils failed to cause significant killing of amoebae in the presence of either FCS or antiserum (Fig. 1) . Similarly, neutrophils treated with sCM failed to cause killing of acanthamoebae in the presence of FCS. However, the sCM-treated neutrophils caused approximately 40% killing in the presence of rabbit anti-amoeba antiserum (P < 0.001). Effect of sCM-treated MNLs on amoebae. In an endeavor to exclude the possibility that the killing demonstrated under the above conditions was due to an effect of sCM on contaminating MNLs, the ability of sCM to induce amoebicidal activity in MNLs was examined. The MNLs were treated with the same sCM as used above and under the same conditions. The ratio used was 50 MNLs to one amoeba. In addition a control group was added, representing the highly purified neutrophil population. The effect of this cell type was examined also at a ratio of 50 neutrophils to one amoeba. The results showed that the highly purified neutrophil population caused significant (approximately 50%) killing of amoebae (Fig. 2) . Although the MNLs showed some effect (approximately 15% killed), this was not significant (Fig. 2) .
Adsorption of the serum promoting activity. It was evident that serum factors in the antiserum were important in promoting the killing of amoebae by sCM-treated neutrophils. To see whether these factors were specific, the effect of prior adsorption of the antiserum with acanthamoebae was examined. Adsorption of the serum with acanthamoebae reduced the amoeba agglutination titer from 1/32 to 1/2. The killing of amoebae by sCM-treated neutrophils was completely abolished if the adsorbed antiserum was used in lieu of the nonadsorbed serum (Fig. 3) .
Effects of direct PHA treatment of neutrophils. Since PHA contamination of the sCM is conceivable, the likelihood that PHA was the active agent in the sCM had to be excluded. The ability of various concentrations of PHA (0.002 to 2 ,ug/ml) to enhance the amoebicidal properties of neutrophils was examined. The results showed that neutrophils treated with PHA in a similar manner to their treatment with sCM caused no significant killing of amoebae in the presence of antiserum (data not presented).
Effect of sCM on acanthamoebae. Supernatants from stimulated MNLs are likely to contain cytotoxic substances, e.g., lymphocytotoxin. The killing of amoebae by neutrophils may be merely a result of adsorption of the lymphokine by the neutrophils, which then present it directly to the amoebae.
To exclude this possibility, the sCM was examined for the presence of amoebicidal activity. In these experiments, the same setup as used for the experiments involving neutrophils was adopted. The amoebae were incubated with 0.1, 1.0, or 10.0% sCM. The results showed that these concentrations of sCM had no amoebicidal effect. In fact, at the higher concentration the sCM increased the growth of acanthamoebae in culture by approximately 20% (0.01 > P > 0.001).
Effect of changing the neutrophil-to-target-cell ratio. Assays were conducted at effector-to-target-cell ratios of 80:1, 40: 1, 10: 1, and 1:1. The results showed that a related decrease in the degree of killing occurred, with a decrease in effector cells (Fig. 4) . Significant killing was still observed at a ratio of 1:1.
Adherence of neutrophils to amoebae. Examination of neutrophil-amoeba interaction showed that comparable adherence of nsCM-and sCM-treated neutrophils to amoebae occurred (Fig. 5) . Adherence was markedly increased in the presence of antiserum. A number of neutrophils were seen to adhere to a single amoeba (Fig. 6 ). Effects of normal serum. Since it is known that normal serum may contain natural antibodies to A. culbertsoni (5, 13) , the effect of substituting normal rabbit serum for the antiserum was examined. The results showed that sCMtreated neutrophils were capable of killing acanthamoebae in the presence of normal rabbit serum (percent killing, 30; 0.01 > P > 0.001). Normal rabbit serum adsorbed with the amoebae failed to aid the sCM-treated neutrophils in killing (percent killing, 4.5). Similarly, 5% human serum (heated at 56°C for 30 min) was capable of promoting amoeba killing by sCM-treated neutrophils (percent killing, 39.2; P < 0.001).
Modification of neutrophil-mediated cytotoxicity for tumor cells. The neutrophil-mediated antibody-dependent cytotoxicity against three tumor cell types was examined for neutrophils treated with either nsCM or sCM. Studies with the B16 melanoma tumor cell line showed that in the presence of rabbit antiserum to the tumor neither nonconditioned medium (NCM)-nor nsCM-treated neutrophils showed any significant cytotoxicity against the target (Fig. 7) . However, when neutrophils were pretreated with sCM, a significant level of cytotoxicity was observed in the presence of antiserum but not in its absence (Fig. 7) . Similar experiments with the K562 erythroid myeloid cell line showed that there was a low but nonsignificant level of neutrophil-mediated antibody-dependent cytotoxicity by neutrophils treated with either NCM or nsCM. Treatment of neutrophils with sCM, however, resulted in an increase in the cytotoxicity (Fig. 8) .
In a third set of experiments, the antibody-dependent cell-mediated cytotoxicity was examined by a system previously adopted to demonstrate enhancement of neutrophil antibody-dependent cell-mediated cytotoxicity by colony- stimulating factor (44) . This was the TNP-tagged P815 tumor target. The results of our experiments demonstrated that neutrophils were cytotoxic for the P815 target in the presence of antibody (Fig. 9 ). In addition, the neutrophilmediated cytotoxicity against the target was enhanced by prior treatment of leukocytes with sCM (Fig. 9) .
With respect to all three antibody-dependent cellmediated cytotoxicity systems, it was shown that sCM had no direct tumoricidal activity (data not presented). In addition it was found that MNLs used at their highest possible contamination (5%), i.e., effector-to-target-cell ratio of 5:1, showed no significant cytotoxicity when these leukocytes were treated with sCM (data not presented).
Alteration of neutrophils in the killing of phagocytosable microorganisms by sCM. Since the amoeba is relatively large compared with the neutrophil, an extracellular killing mechanism is involved, and it was therefore of importance to see the status of the neutrophil treated with sCM in relation to killing of microorganisms which are killed after their confinement within phagocytic vacuoles. In this study, the bacteria S. aureus and Streptococcus pneumoniae and the opportunistic fungal pathogen T. glabrata were used.
The data presented in Fig. 10 showed that at a ratio of 20 S. aureus cells to one neutrophil, there was a significant difference between neutrophils treated with nsCM or sCM in the killing of S. aureus cells. Neutrophils treated with nsCM reduced the bacterial inoculum by 15% after 60 min, whereas leukocytes treated with sCM reduced it by 60% (0.05 > P > 0.02). In a separate set of experiments we found no significant difference in the killing of S. aureus cells by neutrophils treated with nsCM and NCM (data not presented). In a third set of experiments the ratio of bacteria to neutrophils was changed; ratios of 20:1, 10:1, and 2:1 were used. We found that a difference between neutrophils treated with nsCM and sCM, although apparent at a ratio of 10:1, was clearly evident at a ratio of 20:1 (Table 1) . At a ratio of 2:1, at which the neutrophils killed a high proportion of bacteria, a difference was not obtained.
Similar studies conducted with Streptococcus pneumoniae showed that the killing of this organism by neutrophils could be enhanced by treating the leukocytes with sCM (Fig.  11) . Again, it was shown that the ability to show a difference between the killing by sCM-and nsCM-treated neutrophils was dependent on the ratio of bacteria to neutrophils used (data not presented).
Neutrophils treated with sCM showed significant enhancement of killing of T. glabrata compared with nsCM-treated leukocytes (Fig. 12) . After 90 min of incubation the percentage killed with nsCM and sCM was 5 and 55%, respectively. This effect by sCM, as in the studies with bacteria, was observed only at the higher ratio of organism to neutrophil.
Effect of sCM on neutrophil migration and metabolic activity. A well-characterized lymphokine with activity on neutrophils is leukocyte inhibitory factor (LIF). The principal effect of LIF on neutrophils is to inhibit their migration rate. The sCM was examined for the presence of neutrophil migration inhibitory activity. The results showed that neutrophils treated with sCM but not nsCM were inhibited in their locomotion (Fig. 13) . Activation of the NADPH oxidase activity in neutrophils is an important step in the production of oxygen metabolites which may directly or in combination with other components (such as myeloperoxidase) of the neutrophil kill microorganisms and tumor cells. The NADPH oxidase activity. The effects on these two parameters of treating neutrophils with sCM or nsCM were examined. The results showed that the sCM induced both a burst of chemiluminescence and HMP shunt activity in neutrophils ( Fig. 14 and 15 ).
DISCUSSION
The virulent Acanthamoeba sp. A. culbertsoni was poorly killed or not killed by NCM-or nsCM-treated neutrophils in the presence of antibody. However, the same neutrophils exposed for 1 h to sCM demonstrated significant killing of acanthamoebae in the presence of antiserum. Previously a similar result was obtained with another pathogenic amoeba, N. fowleri (11) . Normal rabbit serum also contained a principle(s) which aided sCM-treated neutrophils in killing acanthamoebae. This, as well as the activity in the antiserum, could be adsorbed with the amoebae, suggesting that it is antibody. Consistent with our previous findings with naegleriae (11) , the addition of antiserum to acanthamoebae in the absence of neutrophils enhanced the growth of amoebae. It may therefore be argued that comparisons should be made with this result, in which case neutrophils treated with NCM or nsCM would give higher killing values. However, we are against this interpretation because, as we argued for naegleriae, amoebae have the ability to redistribute, cap, and internalize surface-bound antibody (11, 17) . This phenomenon is unlikely to occur if neutrophils bind to the amoebae via the Fc receptor. Alteration of neutrophils by sCM is unlikely to be due to possible PHA contamination. First, the MNLs were washed after PHA stimulation and supernatants were collected after a subsequent reculture in the absence of this mitogen. Second, it was shown that neutrophils exposed to a range of concentrations of PHA did not display enhaced killing of amoebae.
The neutrophil preparation used in these studies was of high purity (>96%) (16) , and it is unlikely that any MNL contamination was responsible. Evidence against the involvement of MNLs is that the neutrophil preparation was still effective at an effector-to-target-cell ratio of 1:1. Second, exposure of MNLs to sCM did not endow these leukocytes with amoebicidal activity. This finding also suggests that MNLs do not display natural killing against this protazoon. Previously it was demonstrated that Giardia lamblia is killed by normal human peripheral blood monocytes in the' absence of antibody or complement (38) .
Owing to the relatively large size of the amoeba, it can bind many neutrophils to its surface. Although binding was promoted by the antiserum, there was no significant difference between the ability of sCM-and nsCM-treated neutrophils to bind to amoebae. This demonstrates another example of antibody-dependent, neutrophil-mediated killing involving an extracellular mechanism and may be similar to that demonstrated with other targets, including tumnor cells (2, 23) , virus-infected cells. (21, 37) , and helminths (8) . Since neutrophils treated with sCM did not display the stimulated amoebicidal properties in the absence of antibody, the results suggest that close contact is required for the killing.
The sCM was neither amoebicidal nor tumoricidal. It is therefore unlikely that the activity conferred on neutrophils was a result of passive transfer of amoebicidal activity to the leukocyte. This is further supported by the finding that MNLs treated in the same manner as neutrophils were not amoebicidal. It is most probable that the stimulated antimicrobial property of the neutrophil is a result of a modulated function of this leukocyte.
Among the factors released by MNLs which modify neutrophil function are those which inhibit the migration of these leukocytes and includes LIF (25, 34) and neutrophil migration inhibition factor T, which appears to be distinct from LIF (45, 46 gets, and we have found that human interferon stimulates the HMP shunt activity of human neutrophils (12) .
This study raises the possibility that neutrophils could participate in host resistance to acanthamoebae. Normal human serum has been shown to contain antibodies to A. ulbertsoni (5, 13) , and these may function to aid neutrophils in the killing of amoebae. Since the amoebae are able to activate complement by the alternative pathway (13), complement may also act as a recognition factor in serum in the absence of antibody, as occurs with naegleriae (11) . Hematogenous spread by acanthamoebae most likely occurs in individuals who are chronically ill or who are undergoing immunosuppressive therapy (29, 30) ; it is probably a result of the immunocompromised status of the individuals. Healthy individuals, besides having adequate levels of antibodies and complement, have the potential to produce lymphokines rapidly because of preexisting sensitization (6) . These factors may be responsible for the pathogenic behavior of acanthamoebae.
Our findings show that neutrophils can be influenced by MNL mediators in their expression of antimicrobial killing properties. Although results of different investigators do not concur regarding the ability of supernatants such as those studied here to increase neutrophil killing of smaller microorganisms such as bacteria, it is evident from our study that sCM increases the killing of bacteria and fungi. It is, however, important to note that the conditions under which enhancement of neutrophil-mediated killing of the smaller organisms was demonstrated required the neutrophils to be subjected to high ratios of microorganism to leukocyte.
Potentiation of neutrophil activity by lymphokines or monokines or both may be of major significance in those circumstances in which microorganisms evade antimicrobial activities of neutrophils (7, 22) .
